[go: up one dir, main page]

MX9305230A - Utilizacion de ciertos surfactantes anionicos para mejorarla efectividad antimicrobiana de composiciones oftalmicas. - Google Patents

Utilizacion de ciertos surfactantes anionicos para mejorarla efectividad antimicrobiana de composiciones oftalmicas.

Info

Publication number
MX9305230A
MX9305230A MX9305230A MX9305230A MX9305230A MX 9305230 A MX9305230 A MX 9305230A MX 9305230 A MX9305230 A MX 9305230A MX 9305230 A MX9305230 A MX 9305230A MX 9305230 A MX9305230 A MX 9305230A
Authority
MX
Mexico
Prior art keywords
anionic surfactants
ophthalmic compositions
improve
antimicrobial effectiveness
certain anionic
Prior art date
Application number
MX9305230A
Other languages
English (en)
Inventor
Ernesto J Castillo
Yusuf Ali
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of MX9305230A publication Critical patent/MX9305230A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se utiliza ciertos surfactantes aniónicos para mejorar la efectividad antimicrobiana en confortables composiciones oftálmicas de liberación sostenida, que contienen polielectrolitos, tales como polímeros de carboxivinilo, polímeros de ácido sulfónico de poliestireno y resinas de intercambio catiónico, así como por lo menos un ingrediente activo.
MX9305230A 1992-08-28 1993-08-27 Utilizacion de ciertos surfactantes anionicos para mejorarla efectividad antimicrobiana de composiciones oftalmicas. MX9305230A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93722892A 1992-08-28 1992-08-28

Publications (1)

Publication Number Publication Date
MX9305230A true MX9305230A (es) 1994-02-28

Family

ID=25469650

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305230A MX9305230A (es) 1992-08-28 1993-08-27 Utilizacion de ciertos surfactantes anionicos para mejorarla efectividad antimicrobiana de composiciones oftalmicas.

Country Status (9)

Country Link
EP (1) EP0590786B1 (es)
JP (1) JP2594877B2 (es)
AT (1) ATE160503T1 (es)
AU (1) AU666957B2 (es)
DE (1) DE69315406T2 (es)
DK (1) DK0590786T3 (es)
ES (1) ES2111717T3 (es)
GR (1) GR3025769T3 (es)
MX (1) MX9305230A (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554367A (en) * 1984-10-31 1996-09-10 Alcon Laboratories, Inc. Compositions for treatment of glaucoma
AU671374B2 (en) * 1993-08-13 1996-08-22 Alcon Laboratories, Inc. Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
CA2270349A1 (en) * 1996-11-01 1998-05-14 Jesse A. May Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma
EP1024810A4 (en) * 1997-06-26 2003-06-11 Merck & Co Inc METHOD FOR OPTIMIZING RETINAL AND THE HEALTH OF THE OPTICAL NERVE
US6335335B2 (en) 1997-11-05 2002-01-01 Senju Pharmaceutical Co., Ltd. Prolonged-action eye drop
DE69839152T2 (de) * 1997-11-05 2009-02-26 Senju Pharmaceutical Co., Ltd. Augentropfen mit verlängerter freisetzung
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
AU4602399A (en) * 1998-06-30 2000-01-24 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Prolonged release ophthalmic compositions containing a fluoroquinolone
BR9914813A (pt) 1998-10-27 2001-07-03 Alcon Lab Inc Sistema conservante para composições farmacêuticas administráveis topicamente
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
US7045121B2 (en) 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
US20040194800A1 (en) * 2003-03-05 2004-10-07 Jeanne Chang Use of sulfonated polystyrene polymers in hard surface cleaners to provide easier cleaning benefit
EP1654002B2 (en) 2003-08-07 2014-01-29 Allergan, Inc. Compositions for delivery of therapeutics into the eyes
US7678578B2 (en) * 2005-02-07 2010-03-16 Beckman Coulter, Inc. Cell permeabilization and stabilization reagent and method of use
US7842714B2 (en) 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
US9192571B2 (en) 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
KR20130100273A (ko) * 2010-08-27 2013-09-10 와카모토 세이야꾸 가부시끼가이샤 점안용 수성 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275503A (en) * 1964-08-26 1966-09-27 Patterson Co C Method for the protection of loci susceptible to the growth of undesired microorganisms
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods

Also Published As

Publication number Publication date
EP0590786B1 (en) 1997-11-26
AU666957B2 (en) 1996-02-29
HK1004773A1 (en) 1998-12-04
ES2111717T3 (es) 1998-03-16
JP2594877B2 (ja) 1997-03-26
DE69315406T2 (de) 1998-03-19
DK0590786T3 (da) 1998-08-10
DE69315406D1 (de) 1998-01-08
EP0590786A1 (en) 1994-04-06
ATE160503T1 (de) 1997-12-15
JPH06211694A (ja) 1994-08-02
GR3025769T3 (en) 1998-03-31
AU4440193A (en) 1994-03-03

Similar Documents

Publication Publication Date Title
MX9305230A (es) Utilizacion de ciertos surfactantes anionicos para mejorarla efectividad antimicrobiana de composiciones oftalmicas.
CA2104917A1 (en) Use of Certain Anionic Surfactants to Enhance Antimicrobial Effectiveness of Ophthalmic Compositions
SV1994000028A (es) Nuevas sulfonilamino pirimidinas, ref. 10916 sv.
DE69123795D1 (de) Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau
PT735890E (pt) Misturas de 2',3'-didesoxi-inosina e hidroxicarbamida para inibicao da disseminacao retroviral
ES2191048T3 (es) Derivados de oxazolidinona y compuestos farmaceuticos que los contienen.
NO923975D0 (no) 2-aminometyl-kroman
BR9810084A (pt) Panos antimicrobianos
FI961809A0 (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
ATE323488T1 (de) Nitratsalze von antimikrobiellen wirkstoffen
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
BR0014129A (pt) Tensoativos à base de aminoácido aniÈnico para aumento da eficácia antimicrobiana de composições farmacêuticas tópicas
DK0868909T3 (da) Opthalmisk bæreropløsning
CO5070657A1 (es) Composiciones farmaceuticas para tratar infecciones virales y metodo para hacerlas
BR0011860A (pt) Composições antibacterianas e processo para redução de uma população de bactérias sobre uma superfìcie
BR9814299A (pt) Aminobiguanidas e o seu uso para desinfetarlentes de contato e preservar composiçõesfarmacêuticas
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
ES2159403T3 (es) Poliuretanos termoplasticos que contienen principios activos.
NO954506D0 (no) Hellbare, topiske formuleringer inneholdende polymert materiale, glycoler og glycerider
BR0012291A (pt) Fenoxifluorpirimidinas
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
ATE10255T1 (de) Pharmazeutische mischung.
BR9810433A (pt) Composições anti-helmìnticas
BR0014117A (pt) Uso de sabÈes de acido graxo/aminoácido para aumentar a eficácia antimicrobiana de composições farmacêutica tópicas
DE69207777D1 (de) Körperpflegemittel